Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003121821 | SCV003788996 | uncertain significance | not provided | 2022-10-05 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 20 of the FAT2 protein (p.Lys20Arg). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with FAT2-related conditions. This variant is present in population databases (rs766681033, gnomAD 0.2%), and has an allele count higher than expected for a pathogenic variant. |
Ce |
RCV003121821 | SCV004157875 | benign | not provided | 2022-08-01 | criteria provided, single submitter | clinical testing | FAT2: BS1, BS2 |